Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
44
RNR Quote, Financials, Valuation and Earnings
Last price:
$241.88
Seasonality move
:
1.84%
Day range:
$236.10 - $243.08
52-week range:
$208.98 - $300.00
Dividend yield:
0.65%
P/E ratio:
7.72x
P/S ratio:
0.98x
P/B ratio:
1.23x
Volume:
517.7K
Avg. volume:
551.3K
1-year change:
9.17%
Market cap:
$11.8B
Revenue:
$11.6B
EPS (TTM):
$31.35
Analysts' Opinion
-
Consensus RatingRenaissanceRe Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 4 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $274.55, RenaissanceRe Holdings has an estimated upside of 13.44% from its current price of $242.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $231.00 representing 4.55% downside risk from its current price of $242.01.
Fair Value
-
According to the consensus of 7 analysts, RenaissanceRe Holdings has 13.44% upside to fair value with a price target of $274.55 per share.
RNR vs. S&P 500
-
Over the past 5 trading days, RenaissanceRe Holdings has underperformed the S&P 500 by -1.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
RenaissanceRe Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
RenaissanceRe Holdings has grown year-over-year revenues for 1 quarter straight. In the most recent quarter RenaissanceRe Holdings reported revenues of $3.5B.
Earnings Growth
-
RenaissanceRe Holdings earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter RenaissanceRe Holdings reported earnings per share of $3.27.
Enterprise value:
15.3B
EV / Invested capital:
0.77x
Price / LTM sales:
0.98x
EV / EBIT:
6.40x
EV / Revenue:
1.22x
PEG ratio (5yr expected):
0.03x
EV / Free cash flow:
4.20x
Price / Operating cash flow:
3.36x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.21%
Net Income Margin (TTM):
13.32%
Return On Equity:
9.77%
Return On Invested Capital:
8.71%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.4B | $9.5B | $12.5B | $2.6B | $3.5B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$3.62 | $45.26 | $31.35 | $6.94 | $3.27 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.5B | $17.1B | $18.3B | $22.1B | $21.1B | |
| Total Assets | $32.2B | $34.8B | $38.3B | $50.9B | $53.6B | |
| Current Liabilities | $5.4B | $5.2B | $4.4B | $4.8B | $3.5B | |
| Total Liabilities | $21.7B | $24.8B | $27B | $34.9B | $36.6B | |
| Total Equity | $10.5B | $10.1B | $11.2B | $16.1B | $17B | |
| Total Debt | $1.1B | $1.2B | $1.1B | $1.9B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.9B | $2.2B | $3.6B | $683.5M | $157.8M | |
| Cash From Investing | -$3.3B | -$3.4B | -$3.3B | -$304.5M | -$499.4M | |
| Cash From Financing | $908.1M | $1.8B | -$352.6M | -$644.6M | $290.4M | |
| Free Cash Flow | $1.9B | $2.2B | $3.6B | $683.5M | $157.8M | |
RNR
Sector
Market Cap
$11.8B
$603.7M
Price % of 52-Week High
80.67%
84.45%
Dividend Yield
0.65%
2.05%
Shareholder Yield
8.03%
3.98%
1-Year Price Total Return
9.17%
9.07%
Beta (5-Year)
0.286
0.555
Dividend yield:
0.65%
Annualized payout:
$1.56
Payout ratio:
6.92%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$237.77
200-day SMA
Sell
Level
$250.32
Bollinger Bands (100)
Sell
Level
231.69 - 260.51
Chaikin Money Flow
Buy
Level
37.3M
20-day SMA
Buy
Level
$237.29
Relative Strength Index (RSI14)
Buy
Level
53.07
ADX Line
Sell
Level
13.79
Williams %R
Sell
Level
-19.3129
50-day SMA
Buy
Level
$237.63
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
60M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2774)
Sell
CA Score
(Annual)
Level (-1.4683)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.5224)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
Stock Forecast FAQ
In the current month, RNR has received 2 Buy ratings 4 Hold ratings, and 1 Sell ratings. The RNR average analyst price target in the past 3 months is $274.55.
-
Where Will RenaissanceRe Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that RenaissanceRe Holdings share price will rise to $274.55 per share over the next 12 months.
-
What Do Analysts Say About RenaissanceRe Holdings?
Analysts are divided on their view about RenaissanceRe Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RenaissanceRe Holdings is a Sell and believe this share price will drop from its current level to $231.00.
-
What Is RenaissanceRe Holdings's Price Target?
The price target for RenaissanceRe Holdings over the next 1-year time period is forecast to be $274.55 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is RNR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for RenaissanceRe Holdings is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RNR?
You can purchase shares of RenaissanceRe Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RenaissanceRe Holdings shares.
-
What Is The RenaissanceRe Holdings Share Price Today?
RenaissanceRe Holdings was last trading at $241.88 per share. This represents the most recent stock quote for RenaissanceRe Holdings. Yesterday, RenaissanceRe Holdings closed at $242.01 per share.
-
How To Buy RenaissanceRe Holdings Stock Online?
In order to purchase RenaissanceRe Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
